- Email: [email protected]
On-line information service made available to the desalination sector
NEWS
On-line information service made available to the desalination sector
D
ie Deutsche MeerwasserEntsalzung (DME) GmbH, a central contact point in Germany for national and international enquiries on desalination and advanced water treatment, has provided details of a new, on-line information service that is now available to the desalination industry. Called Desalfacts, DME says that it includes: UÊ n¯ÊvÊ>Ê1 ÊVÕÌÀiÃÊÜÌ Ê`iÌ>i`ÊÜ>ÌiÀÊ profiles – helping to identify the main water trends driving opportunities; UÊ `âiÃÊvÊV«>Þ]ÊÕÛiÀÃÌÞÊ>`Ê,ÊEÊ Ê institute profiles (78 of 483 known) – with available technical and financial details; UÊ ÃiÛiÀ>Ê Õ`Ài`Ê`iÃ>>ÌÊ«>ÌÊ«ÀviÃÆ UÊ ÀiÊÌ >Ê>ÊÌ ÕÃ>`Ê`iÃ>>ÌÊ«>ÌiÌÃÊ categorised and organised in a systematic structure; UÊ Õ`Ài`ÃÊvÊ,ÊEÊ Ê>ÀÌViÃÊV>Ìi}ÀÃi`Ê>`Ê organised in a systematic manner; UÊ >ÊvÕVÌ>ʺ}iÊi»ÊÃi>ÀV Êv>VÌÞÆ UÊ iÃ>>ÌÊ ÕÃiÃÃÊÌi}iViÊ - Ê BI) and Desalfacts Mining tool; UÊ / iʺ->ÌÊ7 ëiÀ»Ê>Ài>ÊqÊVÛiÀ}Ê>`ÊÌ>}Ê about areas before they become a trend; and UÊ >Ê,ÊEÊ ÊiÜÃÊ«>}i]ÊÜ V Ê}ÛiÃÊÀiÃi>ÀV iÀÃÊ the opportunity to publish details of what they do.
Contact: Die Deutsche MeerwasserEntsalzung (DME) GmbH, Bismarckstrasse 120, D–47057 Duisburg, Germany. Tel: +49 203 306 4257, www.dme-gmbh.de, www.desalfacts.de/language/en
WaterTAP to host World Water-Tech Summit in October
C
anada’s Water Technology Acceleration Project (WaterTAP) is to host the 3rd World Water-Tech North America Summit. It is set to be held in Toronto on 6–8 October 2015. This year’s summit will focus on building smart, resilient cities through the development and adoption of advanced water technologies. The agenda will feature leading municipalities, technology providers and active investors looking for game-changing technology, products and services. 6
Membrane Technology
Already, more than 30 of the world’s leading water experts have confirmed to speak at the summit, says WaterTAP. ‘This annual summit is a great opportunity to showcase everything Ontario has to offer as a hub for water technology innovation and investment,’ commented WaterTAP’s new president and CEO, Dr Peter Gallant. ‘We look forward to hosting the world’s leading players in smart water technology and wastewater recycling, and to facilitating partnerships between municipalities, technology companies and investors.’ Sponsors of this summit include smart grid leader Fathom, Toronto-based water-tech investor XPV Capital, the Ontario Clean Water Agency (OCWA) and WRAIN. WaterTAP was established in 2010 by the government of Ontario under the Water Opportunities Act. It brings a diverse set of experience and guidance to helping water industry entrepreneurs gain access to the resources they need to successfully commercialise their products and services, and grow their businesses. Contact: Water Technology Acceleration Project, 20 Adelaide Street East, 13th Floor, Toronto M5C 2T6, Ontario, Canada. Tel: +1 416 593 0303, www.worldwatertechnorthamerica.com, www.WaterTAPontario.com
Medical membranes market worth $7.2 billion by 2020
T
he global medical membranes market is projected to register approximately $7.2 billion by 2020, in terms of value, at a compound annual growth rate (CAGR) of 9.7% between 2015 and 2020, forecasts a study published by Markets and Markets Inc. The report, entitled ‘Medical Membranes Market by Chemistry (PTFE, PVDF, PE, Modified Acrylics and Others), by Technology (Ultrafiltration, Microfiltration, Reverse Osmosis, Dialysis, Gas Separation, Others), by Application (Hemodialysis, Drug delivery, IV Infusion Filters & Sterile Filtration, Others), and Geography – Trends & Forecast to 2020’, defines and segments the medical membranes market with an analysis and forecast of value and volume. Along with this, the value and volume of the medical membranes market by chemistry, technology, application and region are also discussed. It also identifies the driving and restraining factors for this market, with analysis of opportunities and strengths.
The market is segmented and the value forecast on the basis of important regions, such as Asia–Pacific, North America, Europe, and rest of the world. It covers various key applications of medical membranes, such as haemodialysis, drug delivery, IV infusion filters and sterile filtration. Growth in bio-pharmaceuticals and the new therapeutics sector is leading the growth of this market in North America and Europe, says the study. Membranes are used in the medical industry to meet the high requirements for purity of components. Membranes used for filtration purposes also help to recover materials such as concentrated proteins and enzymes. The drivers of the medical membrane market in North America and Europe relate to the rising cost of product development and manufacturing, pharmaceuticals price control and competition with generics, more severe clinical trial hurdles and specialised labelling, and more stringent environment regulations. Germany, the largest market for medical membranes in Europe, is projected to register over 6% CAGR growth between 2015 and 2020. The USA is the largest market in North America and it is projected to grow at 8.10% between 2015 and 2020. Developing economies of Asia, namely China and India, are also projected to register a high growth rate over the next five years. The haemodialysis application registered strong growth in 2014 as incidences of diabetes and kidney failure are increasing and this trend is projected to continue for the next five years. Asia–Pacific countries such as China and India are projected to account for highest medical membranes market, in terms of value, by 2020. This region is projected to register high growth rate in the in the next five years mainly because of the increasing medical care market and a rise in regulations in this region. India and China are also two countries with the highest prevalence of diabetes, which can lead to high incidences of kidney failure – thus leading to higher demand for haemodialysis in this region. This, along with more companies adopting good manufacturing practices for manufacturing pharmaceuticals, is driving the demand for medical membranes, says the report. The growing economies and demographics of the Asia–Pacific region are projected to have high growth potential in the medical membranes market over the next five years. The rise in the healthcare market is the main reason leading to growth in India. Contact: Markets and Markets Inc, 4400 NE 77th Avenue, Suite 275, Vancouver, WA 98662, USA. Tel: +1 888 600 6441, www.marketsandmarkets.com
September 2015
On-line information service made available to the desalination sector
D
ie Deutsche MeerwasserEntsalzung (DME) GmbH, a central contact point in Germany for national and international enquiries on desalination and advanced water treatment, has provided details of a new, on-line information service that is now available to the desalination industry. Called Desalfacts, DME says that it includes: UÊ n¯ÊvÊ>Ê1 ÊVÕÌÀiÃÊÜÌ Ê`iÌ>i`ÊÜ>ÌiÀÊ profiles – helping to identify the main water trends driving opportunities; UÊ `âiÃÊvÊV«>Þ]ÊÕÛiÀÃÌÞÊ>`Ê,ÊEÊ Ê institute profiles (78 of 483 known) – with available technical and financial details; UÊ ÃiÛiÀ>Ê Õ`Ài`Ê`iÃ>>ÌÊ«>ÌÊ«ÀviÃÆ UÊ ÀiÊÌ >Ê>ÊÌ ÕÃ>`Ê`iÃ>>ÌÊ«>ÌiÌÃÊ categorised and organised in a systematic structure; UÊ Õ`Ài`ÃÊvÊ,ÊEÊ Ê>ÀÌViÃÊV>Ìi}ÀÃi`Ê>`Ê organised in a systematic manner; UÊ >ÊvÕVÌ>ʺ}iÊi»ÊÃi>ÀV Êv>VÌÞÆ UÊ iÃ>>ÌÊ ÕÃiÃÃÊÌi}iViÊ - Ê BI) and Desalfacts Mining tool; UÊ / iʺ->ÌÊ7 ëiÀ»Ê>Ài>ÊqÊVÛiÀ}Ê>`ÊÌ>}Ê about areas before they become a trend; and UÊ >Ê,ÊEÊ ÊiÜÃÊ«>}i]ÊÜ V Ê}ÛiÃÊÀiÃi>ÀV iÀÃÊ the opportunity to publish details of what they do.
Contact: Die Deutsche MeerwasserEntsalzung (DME) GmbH, Bismarckstrasse 120, D–47057 Duisburg, Germany. Tel: +49 203 306 4257, www.dme-gmbh.de, www.desalfacts.de/language/en
WaterTAP to host World Water-Tech Summit in October
C
anada’s Water Technology Acceleration Project (WaterTAP) is to host the 3rd World Water-Tech North America Summit. It is set to be held in Toronto on 6–8 October 2015. This year’s summit will focus on building smart, resilient cities through the development and adoption of advanced water technologies. The agenda will feature leading municipalities, technology providers and active investors looking for game-changing technology, products and services. 6
Membrane Technology
Already, more than 30 of the world’s leading water experts have confirmed to speak at the summit, says WaterTAP. ‘This annual summit is a great opportunity to showcase everything Ontario has to offer as a hub for water technology innovation and investment,’ commented WaterTAP’s new president and CEO, Dr Peter Gallant. ‘We look forward to hosting the world’s leading players in smart water technology and wastewater recycling, and to facilitating partnerships between municipalities, technology companies and investors.’ Sponsors of this summit include smart grid leader Fathom, Toronto-based water-tech investor XPV Capital, the Ontario Clean Water Agency (OCWA) and WRAIN. WaterTAP was established in 2010 by the government of Ontario under the Water Opportunities Act. It brings a diverse set of experience and guidance to helping water industry entrepreneurs gain access to the resources they need to successfully commercialise their products and services, and grow their businesses. Contact: Water Technology Acceleration Project, 20 Adelaide Street East, 13th Floor, Toronto M5C 2T6, Ontario, Canada. Tel: +1 416 593 0303, www.worldwatertechnorthamerica.com, www.WaterTAPontario.com
Medical membranes market worth $7.2 billion by 2020
T
he global medical membranes market is projected to register approximately $7.2 billion by 2020, in terms of value, at a compound annual growth rate (CAGR) of 9.7% between 2015 and 2020, forecasts a study published by Markets and Markets Inc. The report, entitled ‘Medical Membranes Market by Chemistry (PTFE, PVDF, PE, Modified Acrylics and Others), by Technology (Ultrafiltration, Microfiltration, Reverse Osmosis, Dialysis, Gas Separation, Others), by Application (Hemodialysis, Drug delivery, IV Infusion Filters & Sterile Filtration, Others), and Geography – Trends & Forecast to 2020’, defines and segments the medical membranes market with an analysis and forecast of value and volume. Along with this, the value and volume of the medical membranes market by chemistry, technology, application and region are also discussed. It also identifies the driving and restraining factors for this market, with analysis of opportunities and strengths.
The market is segmented and the value forecast on the basis of important regions, such as Asia–Pacific, North America, Europe, and rest of the world. It covers various key applications of medical membranes, such as haemodialysis, drug delivery, IV infusion filters and sterile filtration. Growth in bio-pharmaceuticals and the new therapeutics sector is leading the growth of this market in North America and Europe, says the study. Membranes are used in the medical industry to meet the high requirements for purity of components. Membranes used for filtration purposes also help to recover materials such as concentrated proteins and enzymes. The drivers of the medical membrane market in North America and Europe relate to the rising cost of product development and manufacturing, pharmaceuticals price control and competition with generics, more severe clinical trial hurdles and specialised labelling, and more stringent environment regulations. Germany, the largest market for medical membranes in Europe, is projected to register over 6% CAGR growth between 2015 and 2020. The USA is the largest market in North America and it is projected to grow at 8.10% between 2015 and 2020. Developing economies of Asia, namely China and India, are also projected to register a high growth rate over the next five years. The haemodialysis application registered strong growth in 2014 as incidences of diabetes and kidney failure are increasing and this trend is projected to continue for the next five years. Asia–Pacific countries such as China and India are projected to account for highest medical membranes market, in terms of value, by 2020. This region is projected to register high growth rate in the in the next five years mainly because of the increasing medical care market and a rise in regulations in this region. India and China are also two countries with the highest prevalence of diabetes, which can lead to high incidences of kidney failure – thus leading to higher demand for haemodialysis in this region. This, along with more companies adopting good manufacturing practices for manufacturing pharmaceuticals, is driving the demand for medical membranes, says the report. The growing economies and demographics of the Asia–Pacific region are projected to have high growth potential in the medical membranes market over the next five years. The rise in the healthcare market is the main reason leading to growth in India. Contact: Markets and Markets Inc, 4400 NE 77th Avenue, Suite 275, Vancouver, WA 98662, USA. Tel: +1 888 600 6441, www.marketsandmarkets.com
September 2015